Direct Meds GLP-1 vs Gala: Which GLP-1 Provider Is Better?
Short answer: Direct Meds GLP-1 scores higher on our rubric, 7.9/10 against 7.2/10. Full reasoning, pricing and the cases where the other one wins are below.
Direct Meds GLP-1 beats Gala overall, scoring 7.9/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Direct Meds GLP-1 is from $297/mo; Gala is from $149/mo. Choose Direct Meds GLP-1 for users who value published format-specific pricing and can independently monitor billing and cancellation. Choose Gala for tirzepatide-first patients who want a lower yearly-plan rate (microdose $149/mo or full-dose $179/mo) plus a dedicated ios + android tracker app for daily progress logging.
A side-by-side look at Direct Meds GLP-1 and Gala to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Direct Meds GLP-1
#8 of 54Compounded GLP-1 program with published format-specific prices, offset by a sharply negative BBB complaint record around billing, cancellation, and fulfillment.
Visit Direct Meds GLP-1Gala
#34 of 54Telehealth platform focused on compounded tirzepatide, both microdose and full-dose tiers, alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.
Visit Gala| Feature | Direct Meds GLP-1 | Gala |
|---|---|---|
| Why each one | Thorough clinical consultations focused on medical-grade patient experience rather than quick-turnaround prescribing. | The dedicated 'Gala GLP-1 Tracker' app on BOTH iOS and Android, paired with a $149/mo microdose tirzepatide tier on a yearly commitment plan; most compounded-only platforms offer neither a first-party tracking experience nor an explicit microdose pricing tier. |
| Our Score | 7.9/10 | 7.2/10 |
| Headline Price | from $297/mo | from $149/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users who value published format-specific pricing and can independently monitor billing and cancellation | Tirzepatide-first patients who want a lower yearly-plan rate (microdose $149/mo or full-dose $179/mo) plus a dedicated iOS + Android tracker app for daily progress logging |
| Watch out for | Compounded medications only, no brand-name Wegovy, Zepbound, or Ozempic on the menu | Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded tirzepatide. |
| Ranking | #8 | #34 |
| Get started | Visit Direct Meds GLP-1 | Visit Gala |
Pros & Cons Compared
Direct Meds GLP-1
Pros
- +The published $297/mo compounded semaglutide injection tier includes medication, consultations, shipping, and pharmacy fees
- +Format-specific prices are published on the site, which makes the advertised medication and service bundle easier to compare
- +Fast pharmacy fulfillment: most orders ship within 48 hours of provider approval
- +Responsive customer support with live chat available during business hours
Cons
- −Compounded medications only, no brand-name Wegovy, Zepbound, or Ozempic on the menu
- −The $297/mo injectable semaglutide rate sits above Henry Meds ($199) and TrimRx (starting at $179); Direct Meds' own sublingual semaglutide drops at $179 are the budget path if the premium stings
- −BBB shows 248 complaints and roughly 1.1/5 customer-review stars, with recurring reports of unauthorized charges, cancellation difficulty, billing confusion, and unfulfilled or delayed orders
Gala
Pros
- +Compounded tirzepatide is $149/mo microdose or $179/mo full-dose on the yearly plan; 3-month pricing is $169/mo microdose or $219/mo full-dose
- +Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android, first-party in-treatment logging is uncommon among compounded-only platforms
- +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
- +All 50 states, free shipping, no insurance required, 24/7 patient support claimed
Cons
- −Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded tirzepatide.
- −Tirzepatide-only on the compounded side, compounded semaglutide is NOT offered, a narrower medication menu than peers like Maximus, Ro, or Henry Meds
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill
- −Initial consultation is typically a sync video visit, but ongoing follow-ups are chat-based (no scheduled ongoing video access), and there are no published labs, no named medical director, no specialty obesity oversight
- −Restrictive refund policy, Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
- −Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn), limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself
Our Verdict
Direct Meds GLP-1 edges out Gala with a score of 7.9/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Direct Meds GLP-1 is from $297/mo; Gala is from $149/mo. Gala offers both brand-name and compounded medications, giving you more flexibility.
Read Full Reviews
Related comparisons
Other matchups readers comparing Direct Meds GLP-1 or Gala tend to look at next.
- Direct Meds GLP-1 vs Willowfrom $299/mo
- Direct Meds GLP-1 vs MyStart Healthfrom $299/mo
- Direct Meds GLP-1 vs SnagRxpublished $69/mo; total not verified
- Gala vs MEDVi$179 first month, then $299/mo
- Gala vs Foundpublished $129/mo; total not verified
- Gala vs TMatesfrom $158/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Direct Meds GLP-1 · 7.9/10